AMPSOURCE BIOPHARMA INC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are TAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD, AVIDBIOTICS CORP and BOGOCH ELENORE S.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Li Qiang | 12 |
#2 | Li Zirui | 9 |
#3 | Li Yuanli | 8 |
#4 | Gao Yongjuan | 6 |
#5 | Chen Si | 5 |
#6 | Dong Zhao | 5 |
#7 | Zhou Chi | 4 |
#8 | Feng Xiong | 4 |
#9 | Sun Naichao | 3 |
#10 | Ma Xinlu | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018032787A1 | Highly glycosylated human growth hormone fusion protein, and manufacturing method and application of same | |
WO2018032639A1 | Activated human blood-clotting factor vii fusion protein, and manufacturing method and application of same |